Literature DB >> 32538907

Bronchoalveolar Lavage and Oleic Acid-Injection in Pigs as a Double-Hit Model for Acute Respiratory Distress Syndrome (ARDS).

René Rissel1, Moritz Gosling2, Robert Ruemmler2, Alexander Ziebart2, Erik K Hartmann2, Jens Kamuf2.   

Abstract

The treatment of ARDS continues to pose major challenges for intensive care physicians in the 21st century with mortality rates still reaching up to 50% in severe cases. Further research efforts are needed to better understand the complex pathophysiology of this disease. There are different well-established animal models to induce acute lung injury but none has been able to adequately mimic the complex pathomechanisms of ARDS. The most crucial factor for the development of this condition is the damage to the alveolar capillary unit. The combination of two well-established lung injury models allow us to mimic in more detail the underlying pathomechanism. Bronchoalveolar lavage (BAL) leads to surfactant depletion as well as alveolar collapse. The repeated instillation of fluid volumes causes subsequent hypoxemia. Surfactant depletion is a key factor of ARDS in humans. BAL is often combined with other lung injury approaches, but not with a second hit followed by oleic acid injection (OAI) yet. Oleic acid injection leads to severely impaired gas exchange, a deterioration of lung mechanics and disruption of the alveolo-capillary barrier. The OAI mimics most of the expected effects of ARDS consisting of extended inflammation of lung tissue with an increase of alveolar leakage and gas exchange impairment. A disadvantage of the combination of different models is the difficulty to determine the influence to the lung injury caused by BAL alone, OAI alone or both together. The model presented in this report represents the combination of BAL and OAI as a new double-hit lung injury model. This new model is easy to implement and an alternative to study different therapeutic approaches in ARDS in the future.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32538907     DOI: 10.3791/61358

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  2 in total

1.  Levosimendan Ameliorates Cardiopulmonary Function but Not Inflammatory Response in a Dual Model of Experimental ARDS.

Authors:  René Rissel; Moritz Gosling; Jens Kamuf; Miriam Renz; Robert Ruemmler; Alexander Ziebart; Erik K Hartmann
Journal:  Biomedicines       Date:  2022-04-29

2.  Comparison of two porcine acute lung injury models: a post-hoc analysis.

Authors:  René Rissel; Miriam Renz; Katja Mohnke; Julian Riedel; Katharina Ritter; Alexander Ziebart; Robert Ruemmler; Erik K Hartmann; Jens Kamuf
Journal:  Intensive Care Med Exp       Date:  2022-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.